Literature DB >> 8242603

Overrepresentation of chromosome 12p sequences and karyotypic evolution in i(12p)-negative testicular germ-cell tumors revealed by fluorescence in situ hybridization.

R F Suijkerbuijk1, R J Sinke, A M Meloni, J M Parrington, J van Echten, B de Jong, J W Oosterhuis, A A Sandberg, A Geurts van Kessel.   

Abstract

Human testicular germ-cell tumors (TGCTs) comprise a heterogeneous group of solid neoplasms. These tumors are characterized by the presence of a highly specific chromosomal abnormality, i.e., an isochromosome of the short arm of chromosome 12. At present, this i(12p) chromosome is found in more than 80% of TGCTs. Isochromosome 12p has also been observed in some ovarian and extragonadal germ cell tumors. In the remaining so-called i(12p)-negative TGCTs other abnormalities involving chromosome 12, mainly 12p, can be found. In order to establish whether 12p abnormalities other than i(12p) are a common phenomenon in TGCTs, a panel of 11 i(12p)-negative tumors was investigated using multicolor fluorescence in situ hybridization. All TGCTs examined appeared to contain chromosomal abnormalities involving 12p, resulting in a distinct overrepresentation of short arm sequences. In addition, indications were obtained for a clonal evolution in one of the tumors. Our data suggest that the occurrence of 12p abnormalities is a common phenomenon in i(12p)-negative TGCTs and that these abnormalities, analogous to i(12p), may contribute to the process of tumor development.

Entities:  

Mesh:

Year:  1993        PMID: 8242603     DOI: 10.1016/0165-4608(93)90173-j

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  12 in total

Review 1.  Molecular biology of testicular germ cell tumors.

Authors:  E Vilar; E Calvo; J Tabernero
Journal:  Clin Transl Oncol       Date:  2006-12       Impact factor: 3.405

2.  Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.

Authors:  Rolf I Skotheim; Vera M Abeler; Jahn M Nesland; Sophie D Fosså; Ruth Holm; Urs Wagner; Vivi Ann Flørenes; Nina Aass; Olli P Kallioniemi; Ragnhild A Lothe
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

3.  Detection of chromosome aberrations in paraffin sections of seven gonadal yolk sac tumors of childhood.

Authors:  J Jenderny; E Köster; A Meyer; O Borchers; W Grote; D Harms; U Jänig
Journal:  Hum Genet       Date:  1995-12       Impact factor: 4.132

4.  Unique and important consequences of RECQ1 deficiency in mammalian cells.

Authors:  Sudha Sharma; Robert M Brosh
Journal:  Cell Cycle       Date:  2008-01-30       Impact factor: 4.534

Review 5.  The genomic landscape of testicular germ cell tumours: from susceptibility to treatment.

Authors:  Kevin Litchfield; Max Levy; Robert A Huddart; Janet Shipley; Clare Turnbull
Journal:  Nat Rev Urol       Date:  2016-06-14       Impact factor: 14.432

Review 6.  New insights into the pathology and molecular biology of human germ cell tumors.

Authors:  Friedemann Honecker; J Wolter Oosterhuis; Frank Mayer; Jörg Thomas Hartmann; Carsten Bokemeyer; Leendert H J Looijenga
Journal:  World J Urol       Date:  2004-03-20       Impact factor: 4.226

Review 7.  RecQ helicases: suppressors of tumorigenesis and premature aging.

Authors:  Csanád Z Bachrati; Ian D Hickson
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

8.  Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change.

Authors:  B Summersgill; H Goker; S Weber-Hall; R Huddart; A Horwich; J Shipley
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

9.  Isolation and characterization of pluripotent human spermatogonial stem cell-derived cells.

Authors:  Nina Kossack; Juanito Meneses; Shai Shefi; Ha Nam Nguyen; Shawn Chavez; Cory Nicholas; Joerg Gromoll; Paul J Turek; Renee A Reijo-Pera
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

10.  Human RECQ1 is a DNA damage responsive protein required for genotoxic stress resistance and suppression of sister chromatid exchanges.

Authors:  Sudha Sharma; Robert M Brosh
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.